Dr. Wrangle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414Fax+1 843-937-6110
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
Emory University School of MedicineResidency, Internal Medicine, 2005 - 2008
Tulane University School of MedicineClass of 2005
Certifications & Licensure
SC State Medical License 2014 - 2025
MD State Medical License 2008 - 2015
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer Start of enrollment: 2006 Aug 01
- Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25
Publications & Presentations
PubMed
- IL-15: from discovery to FDA approval.Zihai Li, John Wrangle, Kai He, Jonathan Sprent, Mark P Rubinstein
Journal of Hematology & Oncology. 2025-02-18 - 19 citationsSafety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.Zofia Piotrowska, Daniel Shao-Weng Tan, Egbert F Smit, Alexander I Spira, Ross A Soo
Journal of Clinical Oncology. 2023-09-10 - 1 citationsNovel Collaborations Across Training Programs to Support Mentoring in Sex Differences Research.Aimee L McRae-Clark, Kathleen T Brady, Diana Lee-Chavarria, Jacqueline F McGinty, Kevin M Gray
Journal of Women's Health. 2023-08-01
Press Mentions
DoD Grant Funds Hollings Researcher's Idea to Pursue Gene Therapy for CancerMarch 17th, 2025- Dr. Wrangle Discusses Phase 2b QUILT 3.055 Trial at IASLC 2024 World Conference on Lung CancerSeptember 23rd, 2024
- ImmunityBio Presents Positive Long-Term Overall Survival Data in Non-Small Cell Lung Cancer Patients and Announces Registrational Intent Phase 3 Trials with ANKTIVA® and Checkpoint Immunotherapy at World Conference on Lung CancerSeptember 9th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
